Mattson Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,947
Closed -$372K 238
2025
Q4
$372K Sell
14,947
-11,142
-43% -$281K 0.09% 151
2025
Q3
$665K Sell
26,089
-44,249
-63% -$1.09M 0.16% 134
2025
Q2
$1.7M Sell
70,338
-31,055
-31% -$724K 0.46% 83
2025
Q1
$2.57M Buy
101,393
+19,189
+23% +$502K 0.77% 45
2024
Q4
$2.38M Buy
82,204
+40,207
+96% +$1.09M 0.76% 47
2024
Q3
$1.18M Sell
41,997
-299
-0.7% -$8.72K 0.42% 91
2024
Q2
$1.18M Buy
+42,296
New +$1.16M 0.42% 91

Other funds holding PFE

Mattson Financial Services's PFE Position: Q1 2026 in Review

Mattson Financial Services sold out of Pfizer (PFE) in Q1 2026, closing a stake of 14,947 shares — an estimated $372K sold.

Mattson Financial Services first reported a position in PFE in Q2 2024 and held it in 7 quarters. The position peaked at $2.57M in Q1 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mattson Financial Services reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Mattson Financial Services sold 14,947 Pfizer shares in Q1 2026, an estimated $372K.
  • Mattson Financial Services first reported a position in Pfizer in Q2 2024 and held it in 7 quarters.
  • Mattson Financial Services's Pfizer position peaked at $2.57M in Q1 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mattson Financial Services's 13F filing for Q1 2026, filed 11 May 2026.